Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02088112
Title MEDI4736 (Anti PD-L1) Combined With Gefitinib in Subjects With Non-Small Cell Lung Cancer(NSCLC).
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors MedImmune LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Research Site Tampa Florida 33612 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Seattle Washington 98109 United States Details
Research Site Chuo-ku 104-0045 Japan Details
Research Site Matsuyama-shi 791-0280 Japan Details
Research Site Seoul 03080 Korea, Republic of Details
Research Site Seoul 05505 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field